Ozempic is approved only for Type 2 diabetes, not weight loss
Given similar side effect profiles and the convenience advantage of weekly versus daily dosing, semaglutide has largely superseded liraglutide as the preferred GLP-1 option for most patients
Most research supports 1.21.6 g of protein per kg of body weight per day for anyone in active weight loss, and potentially higher on GLP-1 medications where muscle loss risk is elevated
Milk thistle's silymarin content may help stabilise cell membranes and reduce inflammatory mediators, whilst berberine has demonstrated hepatoprotective effects in some animal studies, potentially through anti-inflammatory and antioxidant pathways
The highly variable nature of AD, along with its various underlying hypotheses and complex pathophysiology, has been blamed for the failure to achieve effective treatments, although this is not the only explanation